US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

38.90

-1.2541-3.12%

Volume:1K

Turnover:39.67K

Market Cap:4.86M

PE:- -

High:39.57

Open:39.57

Low:38.90

Close:40.15

52wk High:45.88

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.07

T/O Rate:0.80%

Dividend:0.62

Dividend Rate:1.60%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Stocks to Watch: Amgen, Nike, Bloom Energy

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

Gilead Sciences (GILD) Receives a Buy from Bernstein

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

Amgen is Maintained at Equal-Weight by Wells Fargo

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/TBXU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.8987,"timestamp":1789070400000,"preClose":40.1528,"halted":0,"volume":1006,"delay":0,"changeRate":-0.03123318921719036,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Pre-Mkt","change":-1.2541,"latestTime":"09-11 09:03:57 EDT","open":39.565,"high":39.565,"low":38.8987,"amount":39673,"amplitude":0.016594,"askPrice":62.23,"askSize":200,"bidPrice":24.88,"bidSize":30,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":38.8987,"sharesOutstanding":100001,"nav":40.132,"aum":5016569.02,"dividendRate":0.015985,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.27,"preClose":38.8987,"latestTime":"16:10 EDT","volume":6,"amount":233.4548,"timestamp":1789071007931,"change":0.3713,"changeRate":0.009545,"amplitude":0},"volumeRatio":0.06686784702601159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.06686784702601159,"shares":125000,"dividePrice":0.6218,"high":39.565,"amplitude":0.016594,"preClose":40.1528,"low":38.8987,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.8987,"committee":-0.73913,"eps":0,"divideRate":0.015985,"volume":1006,"delay":0,"ttmEps":0,"open":39.565,"prevYearClose":31.065,"prevWeekClose":44.3833,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":45.8456,"twentyDayClose":38.3273,"sixtyDayClose":29.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665839324","title":"Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839324","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665839324?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:22","pubTimestamp":1788862967,"startTime":"0","endTime":"0","summary":"BUZZ-Ionis Pharma tumbles after heart drug fails late-stage trial** Ionis Pharmaceuticals'IONS.Oshares fall 12.7% to $50.70 premarket** NovartisNOVN.Sand Ionis said late Friday their experimental drug pelacarsendid not cutthe risk of major heart attacks and strokes in patients with a genetic risk factor in a late-stage trial** The drug successfully lowered a dangerous genetic cholesterol, Lp, but it did not improve overall heart health outcomes** The trial failure was negative for biopharma sector perception because lowering Lp \"did not reduce cardiovascular events in the overall population\", say analysts at Leerink Partners**Amgen'sAMGN.Oand Eli Lilly'sLLY.Ndrugs \"lower Lp more than pelacarsen\" and could now facegreater scrutiny- brokerage** Amgen shares slip 5% to $415.01 before the bell** As of last close, IONS down 26.6% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500PU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1571399168.USD","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU0109394709.USD","SG9999001440.SGD","BK4588","BK4534","BK4566","LU0868494617.USD","LU0058720904.USD","LU1983299246.USD","BK4533","IE0002141913.USD","LU2242652126.USD","BK4585","BBH","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0122379950.USD","LU1023059063.AUD","IONS","LU1057294990.SGD","TBXU","LU0289739699.SGD","04332","BIB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IBBQ","PJP","LU1061106388.HKD","LU2089984988.USD","LU2112291526.USD","BK4599","LU2242646821.SGD","AMGN","BK4581","LU2468319806.SGD","IBB","PBE","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665147329","title":"Why Amgen Stock is Dropping After Swiss Rival's Trial Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665147329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665147329?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:53","pubTimestamp":1788861180,"startTime":"0","endTime":"0","summary":"Big Pharma has been scrambling to restock its pipelines this year-so a disappointing trial from one drugmaker can have an outsize knock-on impact for rivals trying to develop similar treatments.That d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU1023059063.AUD","PJP","LU1983299246.USD","BK4599","SG9999001440.SGD","IBB","LU2242652126.USD","BK4139","PBE","BK4533","BK4585","AMGN","LU0109394709.USD","BIB","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU2089984988.USD","LU1061106388.HKD","TBXU","IE0002141913.USD","LU0320765992.SGD","BK4534","IE00BFTCPJ56.SGD","BK4588","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2242646821.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU0289739699.SGD","BK4581","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","IE0009355771.USD","LU1571399168.USD","LU0868494617.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326246","title":"Amgen Falls After Novartis Trial Setback, BMO Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326246?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859626,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen falls after Novartis trial setback, BMO downgrade** Shares of AmgenAMGN.Oslip 4.8% to $416 premarket** Novartis'NOVN.Scholesterol drug failed in a closely watched study,raising concernsfor ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","SG9999001440.SGD","LU0868494617.USD","LU1061106388.HKD","AMGN","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0320765992.SGD","PBE","IE0002141913.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4139","LU0058720904.USD","LU2089984988.USD","LU2242646821.SGD","LU2112291526.USD","BK4585","LU2242652126.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4533","BBH","BK4588","BK4599","LU1983299246.USD","LU0889565916.HKD","LU0289739699.SGD","TBXU","IBBQ","LU1023059063.AUD","BK4566","IE00BJJMRZ35.SGD","PJP","BIB","IE00B2B36J28.USD","LU0122379950.USD","LU0109394709.USD","LU1571399168.USD","BK4534","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342326","title":"Stocks to Watch: Amgen, Nike, Bloom Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858420,"startTime":"0","endTime":"0","summary":"Amgen : Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis  said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial. Amgen and Eli Lilly  are working on rival treatments. Novartis shares tumbled 10% in Europe, while Eli Lilly shares ticked down.Bloom Energy : The fuel-cell maker is among the companies that will join the S&P 500 later this month, S&P Dow Jones Indices announced late Friday, sending its shares 4% higher premarket. Meanwhile, Nike  will be deleted from the S&P 100. Its shares edged lower premarket.Coinbase Global , Robinhood Markets , Strategy : Shares of companies tied to cryptocurrencies retreated in premarket trading as bitcoin's price slipped more than 1% to trade below $78,500.GameStop  is set to report earnings after markets close.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","04332","LU2089984988.USD","BK4558","COIW","LU1988902786.USD","LU2468319806.SGD","SMST","MEDX","HOOW","BK4578","COIA","09311","LU2294711713.HKD","BK4585","LU1861559042.SGD","SG9999001440.SGD","AMGN","FINX","CONL","IE00B4R5TH58.HKD","LU1642822529.SGD","GMEC","LU0070302665.USD","09399","GMEY","09711","07799","BK4127","LU1267930227.SGD","LU1861220207.SGD","LU1983299246.USD","LU0786609619.USD","BK4595","MTYY","LU0823414551.USD","BK4577","IMST","MSTK","SIMS","PBE","LU0320765489.SGD","APED","IBB","LU2098885051.SGD","BK4007","LU0211331839.USD","BK4146","HOOC","WATS","SMOG","VCLN","LMI3.UK","LU2242646821.SGD","BK4023","HOOD","BLCK","VTWG","HOOG","LU2357125470.USD","TBXU","LU0823414478.USD","COIN","LU0109394709.USD","CTEC","BEG","HOOZ","IE0009355771.USD","BK4541","LU1267930573.SGD","BK4532","LU0128525689.USD","BK4076","COIG","IE00BYQQ9H92.USD","ZAP","IE00BFTCPJ56.SGD","LU0310800379.SGD","WNTR","BK4566","LU0052756011.USD","LU0058720904.USD","LU0476273544.USD","MSDD","BK4581","HOYY","IE00BJT1NW94.SGD","HOOI","IBAT","ICOI","HOOY","MSTP","CONI","MSTR","FRNW","HOII","LU0320765992.SGD","LU1057294990.SGD","MSST","IAI","MSTZ","IE0002141913.USD","07311","BK4596","ICLN","LU0029864427.USD","MSTY.UK","LU0708994859.HKD","LU0823411888.USD","DAPP","IBLC","LU0868494617.USD","BITQ","BK4516","GMEU","BIB","CONY","LU0128525929.USD","BE","GME","BK4112","CNRG","STYL","LU1815336760.USD","LU1861558580.USD","BK4588","HODU","BEZ","IBBQ","LU0310800965.SGD","BBH","FIAT","LU0792757196.USD","LU1267930813.SGD","IE00BJJMRZ35.SGD","LU0444971666.USD","07711","MST","MSTY","LU0889565916.HKD","LU2360107671.USD","PJP","MSTC","BK4547","OWNB","BK4535","BK4561","UPGR","LU0208291251.USD","MSTU","IGME","LU1571399168.USD","LU0957808578.USD","COIO","BK4534","NKE","MSII","COIX","MSOO","IE00BFXG0V08.USD","LU1303367103.USD","BK4539","BK4599","BK4182","HOOX","BK4600","LU1064131342.USD","LU0444973449.USD","LU2264538146.SGD","MSTX","LU1861217088.USD","BK4139","BEC","BEX","BPAY","CONX","LU0289739699.SGD","SMI3.UK","3SMI.UK","LU0889566641.SGD","LU2242652126.USD","BK4533","MSTW","NVS","09799","BKCH","COII","EGGY","LU2112291526.USD","BK4554","LU1061106388.HKD","FDIG","CRPT","3LMI.UK","COYY","07399","LU1023059063.AUD","IE0009354923.USD","LU2506951792.HKD","LU0122379950.USD","LU2543165471.USD","PPH","BK4551","LU2249611893.SGD","ROBN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665230393","title":"Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665230393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665230393?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:27","pubTimestamp":1788856044,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU2468319806.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","LU2089984988.USD","LU0868494617.USD","LU0109394709.USD","LU0289739699.SGD","LU0122379950.USD","SG9999001440.SGD","IBB","LU1057294990.SGD","IE00BJJMRZ35.SGD","PJP","IE00BFTCPJ56.SGD","LU1023059063.AUD","IE00B2B36J28.USD","BBH","LU1983299246.USD","BK4588","TBXU","IE0009355771.USD","BK4566","BK4534","LU1571399168.USD","BK4139","IBBQ","BK4599","BK4585","AMGN","LU1061106388.HKD","LU2242652126.USD","BIB","IE00BJT1NW94.SGD","LU0889565916.HKD","PBE","LU2112291526.USD","IE0002141913.USD","BK4581","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","BK4139","LU0058720904.USD","SG9999001440.SGD","BK4599","LU2089984988.USD","LU0889565916.HKD","NVS","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0109394709.USD","BK4533","IE00B4R5TH58.HKD","BK4578","LU2468319806.SGD","LU0122379950.USD","BK4007","LU1983299246.USD","IBB","PBE","TBXU","LU0868494617.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","MEDX","LU0211331839.USD","BBH","LU1057294990.SGD","LU2112291526.USD","BK4532","BK4585","IE00B2B36J28.USD","PPH","LU0208291251.USD","LU1061106388.HKD","BK4588","LU0320765489.SGD","IE0009355771.USD","AMGN","PJP","LU0320765992.SGD","LU1023059063.AUD","BK4566","LU0070302665.USD","BK4534","NAMS","LU2242652126.USD","BK4581","IBBQ","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665101723","title":"Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665101723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665101723?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:47","pubTimestamp":1788806848,"startTime":"0","endTime":"0","summary":"MILTON ESSEX S.A. ( ($PL:MTN) ) just unveiled an announcement. Milton Essex S.A., acting as sole shareholder of Sanford Biotech, has approved a PLN...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","GNOM","XBI","MTNmain","BK4581","TBXU","CNCR","FBT","LFSC","BK4585","IBBQ","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","IBB","LU0122379950.USD","LU0882574055.USD","GILD","IE00B19Z3B42.SGD","MEDI","LU2468319806.SGD","BIB","LU0114720955.EUR","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU2089984988.USD","LU1934455277.USD","SG9999015978.USD","LU1037948541.HKD","LU1585245621.USD","SG9999015952.SGD","BK4585","SG9999015945.SGD","IE00B7SZLL34.SGD","LU0234570918.USD","LU1934455863.HKD","LU1839511570.USD","BK4550","LU2112291526.USD","BK4578","IBBQ","IE00B3T34201.USD","BMED","IE0002270589.USD","LU1934455194.USD","BK4581","LABU","BK4588","BK4139","IE00BZ1G4Q59.USD","BK4566","XBI","BBH","LU0289739699.SGD","LU0965508806.USD","LU2324357040.USD","LU1778281490.HKD","LU1674673428.USD","XLV","LU0823416689.USD","LU1571399168.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","SG9999001440.SGD","LU2242646821.SGD","01177","LU0868494617.USD","LU1571399168.USD","PJP","LU0289739699.SGD","IE00BJT1NW94.SGD","BK4533","BK4139","BK1521","LU0320765992.SGD","IE00BFTCPJ56.SGD","IBB","IE00B2B36J28.USD","LU1057294990.SGD","BK4581","AMGN","LU2089984988.USD","BK4585","BK1515","BBH","PBE","BK4588","IE00BZ08YS42.EUR","BK1191","LU0889565916.HKD","IE0009355771.USD","IE00BZ08YT58.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242652126.USD","TBXU","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","HK0000165453.HKD","LU0122379950.USD","BK4534","BK4566","LU0058720904.USD","BIB","LU1023059063.AUD","IBBQ","IE00BZ08YR35.GBP","LU1061106388.HKD","BK1589","BK4599","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","NAMS","LU2089284900.SGD","AMGN","MEDI","PPH","IYH","CURE","PBE","IE00BJJMRY28.SGD","LLYX","LLII","MHIP","SGXZ99366536.SGD","RXL","JDOC","SLN","HRTS","THNR","TMED","ILDR","LU0823434583.USD","ELIS","LLYZ","XLV","LU2361044865.SGD","BBH","CANC","TRUH","TBXU","ELIL","MEDX","WDNA","IBBQ","FTXH","LU0097036916.USD","LU2750360641.GBP","FHLC","PJP","LLY","LU1691799644.USD","BIB","LU1267930730.SGD","GDOC","LU1571399168.USD","IHE","OZEM","AGNG","IBB","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BJT1NW94.SGD","PJP","BK4534","BK4588","LU1571399168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4581","LU1983299246.USD","BBH","LU0208291251.USD","IE00B4R5TH58.HKD","BK4578","IE00BFTCPJ56.SGD","LU2242652126.USD","BIB","LU2242646821.SGD","TBXU","BK4532","IBB","NVS","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","LU0289739699.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","BK4007","IE0002141913.USD","AMGN","LU0211331839.USD","LU0889565916.HKD","IE0009355771.USD","PPH","LU0868494617.USD","LU0320765489.SGD","IBBQ","BK4566","LU0070302665.USD","LU1061106388.HKD","PBE","MEDX","BK4599","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365115","title":"A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665365115?lang=en_us&edition=fundamental","pubTime":"2026-09-06 02:01","pubTimestamp":1788631260,"startTime":"0","endTime":"0","summary":"In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.Novartis saw U.S.-listed shares soar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYF","LU2456880835.USD","LU2112291526.USD","BBH","LU0130102774.USD","LU0314106906.USD","LU2236285917.USD","PJP","TFNS","BK4007","BIB","LU0211331839.USD","LU1057294990.SGD","BK4504","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","PBE","PPH","LU0980610538.SGD","LU0320765489.SGD","LU0106831901.USD","LU1074936037.SGD","BK4566","BK4581","BK4533","LU1162221912.USD","BK4559","SG9999001440.SGD","TBXU","BK4139","IBBQ","IBB","LU0889565916.HKD","IE00BSNM7G36.USD","LU1061106388.HKD","MEDX","LU1244550221.USD","LU2125154935.USD","LU2462157665.USD","LU0868494617.USD","LU2360032135.SGD","LU0128525689.USD","BK4599","LU0070302665.USD","NVS","FTXO","LU2242652126.USD","LU0052756011.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665682593","title":"Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2665682593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665682593?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:01","pubTimestamp":1788598891,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ACRS) ), ( ($EYPT) ), ( ($VRTX) ), ( ($GTLB) ) and ( ($NB) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2236285917.USD","BK4097","IE00B19Z9P08.USD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU2362541513.USD","LU1674673428.USD","LU1093756325.SGD","LU0079474960.USD","TBXU","LU1559883803.SGD","IE00B2B36J28.USD","GTLB","LU0289739699.SGD","GNMX","LU0417517546.SGD","LU1093756168.USD","LU2324357040.USD","IE00B19Z3B42.SGD","VRTX","IBB","SG9999001176.SGD","IE0009355771.USD","BIB","IE00B894F039.SGD","VERX","IDNA","BK4607","IE00B4R5TH58.HKD","LU2456880835.USD","IBBQ","BK4533","BK4613","LU1035775433.USD","IE00BZ9MQY76.HKD","SG9999013999.USD","LU2468319806.SGD","LU1778281490.HKD","BBH","LU0757428866.USD","IE00BJJMRZ35.SGD","LU2462157665.USD","IE0002141913.USD","LU1069344957.HKD","LU2089984988.USD","LU2417539215.USD","IE00B19Z9Z06.USD","IE0002270589.USD","PBE","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352504","title":"Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352504","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352504?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:53","pubTimestamp":1788562416,"startTime":"0","endTime":"0","summary":"Amgen EVP, CFO Thomas J.W. Dittrich files initial beneficial ownership statementAmgen EVP and CFO Thomas J.W. Dittrich reported 16,860 common shares in an initial SEC Form 3 filing.Disclaimer:This new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6SPhM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BJT1NW94.SGD","PJP","BK4534","BK4588","LU1571399168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4581","LU1983299246.USD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2242652126.USD","BIB","LU2242646821.SGD","TBXU","IBB","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","LU0289739699.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","IE0002141913.USD","AMGN","LU0889565916.HKD","IE0009355771.USD","LU0868494617.USD","LU1061106388.HKD","IBBQ","BK4566","PBE","BK4599","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","HELX","BBP","EKG","GNOM","IYH","LU0889565916.HKD","NVIB","IDNA","PTH","IEIH","GNMX","TECB","FFOX","BK4196","BK4588","MRNY","GH","PSCH","SYNB","LU0320765992.SGD","PINK","IBB","LFSC","MRNX","TBXU","BK4551","GDOC","BMED","XLVX","LU0109394709.USD","BK4535","BK4585","LABU","MEDI","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665235617","title":"Amgen is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2665235617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665235617?lang=en_us&edition=fundamental","pubTime":"2026-09-05 02:47","pubTimestamp":1788547620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0742534661.SGD","TBXU","BK4559","LU1894683348.USD","LU1571399168.USD","LU0417517546.SGD","LU0130102774.USD","PBE","IE00B4R5TH58.HKD","LU1035773651.USD","LU1061106388.HKD","IYF","LU0868494617.USD","LU1069347547.HKD","BBH","BK4581","TFNS","BIB","IE00BFTCPJ56.SGD","BK4588","LU0971096721.USD","FTXO","KBWB","AMGN","IBBQ","LU0162691827.USD","LU0310799852.SGD","BK4582","BK4534","LU2361044865.SGD","LU0889565916.HKD","LU1814569148.SGD","PJP","LU0708994859.HKD","LU0106831901.USD","BK4533","LU0175139822.USD","LU0128525929.USD","LU1074936037.SGD","LU2361044949.HKD","LU0130517989.USD","IBB","LU0942090050.USD","PGF","IE0002270589.USD","LU0154236417.USD","LU0787776722.HKD","IE00BJT1NW94.SGD","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980438","title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980438","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980438?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:47","pubTimestamp":1788468476,"startTime":"0","endTime":"0","summary":"Regeneron director Kathryn Guarini disposes of 400 common shares worth $340,000Regeneron director Kathryn Guarini sold 400 shares on Sep. 2 at USD 850 per share.She exercised stock options for 400 sha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9s8sKq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","REGN","IBB","LU1917777945.USD","LU0058720904.USD","BK4585","LU0289739699.SGD","BK4139","LU0114720955.EUR","TBXU","LU2237438978.USD","LU2362541273.HKD","LU2023250504.SGD","LU2468319806.SGD","LU0109394709.USD","LU0889565916.HKD","BK4588","LU0320765992.SGD","LU2089984988.USD","LU2106854487.HKD","LU0882574055.USD","LU2362541513.USD","LU0053666078.USD","IBBQ","LU0823416689.USD","LU0823434583.USD","BBH","LU2362540622.SGD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664012018","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664012018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664012018?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:35","pubTimestamp":1788467700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.08% to $151.22 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.Gilead Sciences Inc. closed 3.86% short of its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.17% to $278.43, Pfizer Inc.  fell 0.72% to $28.81, and Abbott Laboratories  fell 1.52% to $108.79.Trading volume  remained 2.3 million below its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1057294990.SGD","LU1037948541.HKD","LU2087621335.USD","LU1571399168.USD","IE0002270589.USD","LU0861579265.USD","LU2112291526.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1037948897.HKD","LU0058720904.USD","SG9999015945.SGD","TMED","IE00BKVL7J92.USD","BK4585","LU1778281490.HKD","LU0289739699.SGD","LU0859254822.USD","BIB","BK4583","BK4550","IE00B19Z3B42.SGD","LU2357627491.SGD","BK4568","BK4139","LU0114720955.EUR","LU1934455277.USD","LU1934455194.USD","LU2324357040.USD","TBXU","IE00B3T34201.USD","LU0234570918.USD","LU1585245621.USD","LU2468319806.SGD","GILD","LU0109394709.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU0889565916.HKD","LU1674673428.USD","MEDI","BK4532","SG9999015952.SGD","BK4588","LU0320765992.SGD","LU2089984988.USD","LU0965508806.USD","LU0882574055.USD","IBBQ","LU0823416689.USD","LU1061106388.HKD","LU1066053197.SGD","BBH","LU0965509010.AUD","LU1023059063.AUD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU1839511570.USD","SG9999015986.USD","BMED","LU0965509283.SGD","LU1934455863.HKD","BK4578","LU1066051498.USD","BK4566","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805389","title":"Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805389","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805389?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453034,"startTime":"0","endTime":"0","summary":"Gilead Sciences ($GILD) announced an update on their ongoing clinical study. Gilead Partner Study Marks Milestone in First-Line Stomach Cancer Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU0965509283.SGD","LU1057294990.SGD","LU0965509101.SGD","IBBQ","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1571399168.USD","TMED","BK4583","IE00B3T34201.USD","GILD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1839511570.USD","LU1934455277.USD","LU2112291526.USD","LU1674673428.USD","TBXU","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU2468319806.SGD","LU1066053197.SGD","SG9999015978.USD","LU1778281490.HKD","LU1934455194.USD","BK4139","LU1585245621.USD","IE00B7SZLL34.SGD","SG9999015945.SGD","IBB","LU0122379950.USD","BK4532","LU1037948541.HKD","LU0861579265.USD","LU1061106388.HKD","LU0823416689.USD","IE00BKVL7J92.USD","BIB","LU2324357040.USD","SG9999015952.SGD","LU0965508806.USD","BK4588","LU0058720904.USD","MEDI","LU1023059063.AUD","BMED","BK4566","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803700","title":"Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803700?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:04","pubTimestamp":1788451496,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. plans to launch a targeted ground gravity survey at its wholly owned ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","IBBQ","LU0289739699.SGD","LU2237438978.USD","LU0109394709.USD","BBH","IE00B19Z3581.USD","BK4588","IE00BJJMRZ35.SGD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU1069344957.HKD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0061475181.USD","LU2362541273.HKD","BK4532","LU2236285917.USD","VRTX","IE0002270589.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU1035775433.USD","TBXU","IE00B19Z9Z06.USD","LU2324357040.USD","IBB","LU0417517546.SGD","IE00BZ9MQY76.HKD","IDNA","SG9999001176.SGD","BK4585","SG9999013999.USD","LU0058720904.USD","BK4139","LU1093756168.USD","IE0002141913.USD","LU2362541513.USD","PBE","LU2362540622.SGD","IE0009355771.USD","LU0320765992.SGD","LU1674673691.USD","LU0823416689.USD","GNMX","IE00B19Z9P08.USD","BIB","LU0889565916.HKD","LU0079474960.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}